Skip to main content
Veterinary Medicines

PA-OLVAC+PM+I Vaccino inattivato in emulsione iniettabile per tacchini

Authorised
  • Newcastle disease virus, Inactivated
  • Avian influenza virus A, H9N2, Inactivated
  • Avian influenza virus A, H6N2, Inactivated
  • Pasteurella multocida, Inactivated
  • Riemerella anatipestifer, serotype 3, Inactivated
  • Riemerella anatipestifer, serotype 1, Inactivated

Identifikacija zdravila

Ime zdravila:
PA-OLVAC+PM+I Vaccino inattivato in emulsione iniettabile per tacchini
Učinkovina:
Pot uporabe:
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Na voljo samo v English
  • Na voljo samo v English
  • Na voljo samo v English
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Na voljo samo v English
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
  • Na voljo samo v English
    1.00
    billion colony forming units
    /
    0.50
    millilitre(s)
Farmacevtska oblika:
  • Emulzija za injiciranje
Withdrawal period by route of administration:
  • Subcutaneous use
    • Turkey
      • Meat and offal
        0
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI01CL
Status dovoljenja:
  • Valid
Authorised in:
Ta podatek za to zdravilo ni na voljo.
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Fatro S.p.A.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Fatro S.p.A.
  • Fatro S.p.A.
Pristojni organ:
  • Ministry Of Health
Številka dovoljenja :
  • 102359
Datum spremembe statusa dovoljenja:

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Italian (PDF)
Objavljeno na: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."